(Q40842277)

English

TAN-1813, a novel Ras-farnesyltransferase inhibitor produced by Phoma sp. taxonomy, fermentation, isolation and biological activities in vitro and in vivo.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

TAN-1813, a novel Ras-farnesyltransferase inhibitor produced by Phoma sp. taxonomy, fermentation, isolation and biological activities in vitro and in vivo (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

(2R,4S,4aS,5R,6R,8aR)-8a-hydroxy-4,6-dimethyl-5-[4-[(3R)-oct-1-en-3-yl]-2,5-dioxopyrrole-3-carbonyl]-2,3,4,4a,5,6-hexahydro-1H-naphthalene-2-carboxylic acid

1 reference

1,2,3,4,4a,5,6,8a-Octahydro-8abeta-hydroxy-4alpha,6alpha-dimethyl-5-[[4-[(S)-1-vinylhexyl]-2,5-dihydro-2,5-dioxo-1H-pyrrole-3-yl]carbonyl]naphthalene-2alpha-carboxylic acid

1 reference

author name string

T Ishii

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Hayashi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Hida

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y Yamamoto

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y Nozaki

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

2000

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/53/8/53_8_765/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.53.765?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

53

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

765-778

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.53.765?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Development of antisense therapeutics. Implications for cancer gene therapy

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Xenopus oocyte germinal-vesicle breakdown induced by [Val12]Ras is inhibited by a cytosol-localized Ras mutant

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

H-ras ribozyme-mediated alteration of the human melanoma phenotype

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

The ras gene family and human carcinogenesis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Cytotoxicity of simvastatin to pancreatic adenocarcinoma cells containing mutant ras gene

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Function and regulation of ras.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Pathways of Ras function: connections to the actin cytoskeleton.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Steady-state kinetic mechanism of Ras farnesyl:protein transferase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

The physiological roles of membrane ergosterol as revealed by the phenotypes of syr1/erg3 null mutant of Saccharomyces cerevisiae

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

The p21 ras C-terminus is required for transformation and membrane association

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Altered growth of human colon cancer cell lines disrupted at activated Ki-ras

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Identification of Ras farnesyltransferase inhibitors by microbial screening

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Phosphatidylinositol-3-OH kinase as a direct target of Ras

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Cell cycle-specific effects of lovastatin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Amphotericin B as a potentiation agent to cytotoxic chemotherapy

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Inhibitors of Ras farnesyltransferases

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Friends and family: the role of the Rab GTPases in vesicular traffic

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Proteins regulating Ras and its relatives

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Kinetic analysis of zinc ligand mutants of mammalian protein farnesyltransferase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Evidence for a catalytic role of zinc in protein farnesyltransferase. Spectroscopy of Co2+-farnesyltransferase indicates metal coordination of the substrate thiolate

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Crystal structure of protein farnesyltransferase at 2.25 angstrom resolution

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Zinc-catalyzed sulfur alkyation:insights from protein farnesyltransferase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

A mechanism for posttranslational modifications of proteins by yeast protein farnesyltransferase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.765

Identifiers

10.7164/ANTIBIOTICS.53.765

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11079798%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40842277&oldid=2141590461"